ITMI931806A0 - Composti inibitpri di acil enzima-a-colesterolo-o-acil transferasi ad attivita' terapeutica , loro uso e composizioni farmaceutiche che li contengono - Google Patents

Composti inibitpri di acil enzima-a-colesterolo-o-acil transferasi ad attivita' terapeutica , loro uso e composizioni farmaceutiche che li contengono

Info

Publication number
ITMI931806A0
ITMI931806A0 IT93MI1806A ITMI931806A ITMI931806A0 IT MI931806 A0 ITMI931806 A0 IT MI931806A0 IT 93MI1806 A IT93MI1806 A IT 93MI1806A IT MI931806 A ITMI931806 A IT MI931806A IT MI931806 A0 ITMI931806 A0 IT MI931806A0
Authority
IT
Italy
Prior art keywords
acil
cholesterol
enzyme
contain
pharmaceutical compositions
Prior art date
Application number
IT93MI1806A
Other languages
English (en)
Inventor
Massimo Bani
Vincenzo Olgiati
Original Assignee
Massimo Bani
Vincenzo Olgiati
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massimo Bani, Vincenzo Olgiati filed Critical Massimo Bani
Priority to ITMI931806A priority Critical patent/IT1270976B/it
Publication of ITMI931806A0 publication Critical patent/ITMI931806A0/it
Priority to GB9415873A priority patent/GB2280675A/en
Priority to JP6204436A priority patent/JPH07149733A/ja
Priority to DE4428025A priority patent/DE4428025A1/de
Publication of ITMI931806A1 publication Critical patent/ITMI931806A1/it
Application granted granted Critical
Publication of IT1270976B publication Critical patent/IT1270976B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ITMI931806A 1993-08-06 1993-08-06 Composti inibitpri di acil enzima-a-colesterolo-o-acil transferasi ad attivita' terapeutica, loro uso e composizioni farmaceutiche che li contengono IT1270976B (it)

Priority Applications (4)

Application Number Priority Date Filing Date Title
ITMI931806A IT1270976B (it) 1993-08-06 1993-08-06 Composti inibitpri di acil enzima-a-colesterolo-o-acil transferasi ad attivita' terapeutica, loro uso e composizioni farmaceutiche che li contengono
GB9415873A GB2280675A (en) 1993-08-06 1994-08-05 ACAT-inhibiting imidazoles
JP6204436A JPH07149733A (ja) 1993-08-06 1994-08-05 治療活性を有するアシル酵素−ａ−コレステロール−ｏ−アシル−トランスフエラーゼの阻害剤化合物、その利用及びそれを含む製薬学的組成物
DE4428025A DE4428025A1 (de) 1993-08-06 1994-08-08 Inhibitoren der Acyl-Enzym-A-Cholesterin-O-Acyl-Transferase mit therapeutischer Wirksamkeit, ihre Verwendung und sie enthaltende pharmazeutische Zusammensetzungen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI931806A IT1270976B (it) 1993-08-06 1993-08-06 Composti inibitpri di acil enzima-a-colesterolo-o-acil transferasi ad attivita' terapeutica, loro uso e composizioni farmaceutiche che li contengono

Publications (3)

Publication Number Publication Date
ITMI931806A0 true ITMI931806A0 (it) 1993-08-06
ITMI931806A1 ITMI931806A1 (it) 1995-02-06
IT1270976B IT1270976B (it) 1997-05-26

Family

ID=11366803

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI931806A IT1270976B (it) 1993-08-06 1993-08-06 Composti inibitpri di acil enzima-a-colesterolo-o-acil transferasi ad attivita' terapeutica, loro uso e composizioni farmaceutiche che li contengono

Country Status (4)

Country Link
JP (1) JPH07149733A (it)
DE (1) DE4428025A1 (it)
GB (1) GB2280675A (it)
IT (1) IT1270976B (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL149145A0 (en) * 1999-11-05 2002-11-10 Warner Lambert Co Prevention of plaque rupture by acat inhibitors
US7884106B2 (en) 2003-08-29 2011-02-08 Kowa Company, Ltd. Method of stabilizing lipid-rich plaque and method of preventing rupture thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1248528B (it) * 1991-06-21 1995-01-19 Pierrel Spa Derivati di eteri e tioeteri (etero) aromatici aventi attivita` antiiperlipidemica, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.

Also Published As

Publication number Publication date
ITMI931806A1 (it) 1995-02-06
DE4428025A1 (de) 1995-02-09
GB9415873D0 (en) 1994-09-28
JPH07149733A (ja) 1995-06-13
IT1270976B (it) 1997-05-26
GB2280675A (en) 1995-02-08

Similar Documents

Publication Publication Date Title
BR1100329A (pt) Composto e formulação farmacêutica
FI955144A (fi) Päällystetyt farmaseuttiset koostumukset
DE69425879D1 (de) Taxolformulierung
FI944832A0 (fi) Farmaseuttinen koostumus
BR9500784A (pt) Composto e formulação farmacêutica
BR9504060A (pt) Composto e formulação farmacêutica
IT8323205A0 (it) Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.
IT1277025B1 (it) Classe di oligonucleotidi fosfodiesterici ad attivita' citotossica composizioni farmaceutiche che li contengono e loro uso
ITMI930582A0 (it) Composizione farmeceutiche ad attivita' analgesica
ITMI932540A0 (it) Composizione farmaceutica
ITMI931325A0 (it) Composizione farmaceutica ad attivita' analgesica
ITMI921235A1 (it) Oligonucleotidi antisenso ad attivita' antitumorale, composizioni farmaceutiche che li comprendono, e loro impieghi
IT1271417B (it) Composti ad attivita' antiistaminica procedimento per la loro preperazione e composizioni farmaceutiche che li contengono.
ITMI931806A0 (it) Composti inibitpri di acil enzima-a-colesterolo-o-acil transferasi ad attivita' terapeutica , loro uso e composizioni farmaceutiche che li contengono
LV10579A (lv) Farmaceitiska kompozicija
ITMI911147A0 (it) Composto ad attivita' terapeutica,sua preparazione e composizioni farmaceutiche che lo contengono
NO306672B1 (no) N,N-dietyl-8,8-dipropyl-2-azaspiro[4,5]decan-2-propanamindimaleat, farmasöytisk blanding omfattende forbindelsen samt anvendelse derav
ITMI930453A1 (it) Composizione farmaceutica avente attivita' antiasmatica
ITRM920045A1 (it) Composizioni farmaceutiche ad attivita' anti-aging.
ITMI911298A1 (it) Composti ad attivita' anticolinesterasi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
ITMI911335A1 (it) Composti ad attivita' anticolinesterasi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
BR1100691A (pt) Composto, e, composição farmacêutica
BR1100960A (pt) Composto, e, composição farmacêutica
BR1100596A (pt) Composto e formulações farmacêuticas
ITMI911380A0 (it) Composti ad attivita' antiinfiammatoria e formulazioni farmaceutiche che li contengono

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960830